S. Kaufmann, How can immunology contribute to the control of tuberculosis?, Nature Reviews Immunology, vol.97, issue.1, pp.20-30, 2001.
DOI : 10.1038/35095558

T. Frieden, T. Sterling, S. Munsiff, C. Watt, and C. Dye, Tuberculosis, The Lancet, vol.362, issue.9387, pp.887-899, 2003.
DOI : 10.1016/S0140-6736(03)14333-4

P. Fine and P. Small, Exogenous Reinfection in Tuberculosis, New England Journal of Medicine, vol.341, issue.16, pp.1226-1227, 1999.
DOI : 10.1056/NEJM199910143411609

A. Van-rie, R. Warren, M. Richardson, T. Victor, and R. Gie, Exogenous Reinfection as a Cause of Recurrent Tuberculosis after Curative Treatment, New England Journal of Medicine, vol.341, issue.16, pp.1174-1179, 1999.
DOI : 10.1056/NEJM199910143411602

N. Parrish, J. Dick, and W. Bishai, Mechanisms of latency in Mycobacterium tuberculosis, Trends in Microbiology, vol.6, issue.3, pp.107-112, 1998.
DOI : 10.1016/S0966-842X(98)01216-5

G. Stewart, B. Robertson, and D. Young, Tuberculosis: a problem with persistence, Nature Reviews Microbiology, vol.177, issue.2, pp.97-105, 2003.
DOI : 10.1073/pnas.002024599

E. Opie and J. Arondon, Tubercle Bacilli in Latent Tuberculous Lesions in Lung Tissue without Tuberculous Lesions, The American Journal of the Medical Sciences, vol.176, issue.3, pp.1-21, 1927.
DOI : 10.1097/00000441-192809000-00064

R. Hernandez-pando, M. Jeyanathan, G. Mengistu, D. Aguilar, and H. Orozco, Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection, The Lancet, vol.356, issue.9248, pp.2133-2138, 2000.
DOI : 10.1016/S0140-6736(00)03493-0

L. Farer, A. Lowell, and M. Meador, EXTRAPULMONARY TUBERCULOSIS IN THE UNITED STATES1, American Journal of Epidemiology, vol.109, issue.2, pp.205-217, 1979.
DOI : 10.1093/oxfordjournals.aje.a112675

P. Hopewell, Overview of clinical tuberculosis Tuberculosis: pathogenesis, protection, and control, pp.25-46, 1994.

E. Munoz-elias, J. Timm, T. Botha, W. Chan, and J. Gomez, Replication Dynamics of Mycobacterium tuberculosis in Chronically Infected Mice, Infection and Immunity, vol.73, issue.1, pp.546-551, 2005.
DOI : 10.1128/IAI.73.1.546-551.2005

L. Tailleux, O. Schwartz, J. Herrmann, E. Pivert, and M. Jackson, Receptor on Human Dendritic Cells, The Journal of Experimental Medicine, vol.71, issue.1, pp.121-127, 2003.
DOI : 10.4049/jimmunol.164.9.4843

URL : https://hal.archives-ouvertes.fr/pasteur-01372712

B. Cousin, O. Munoz, M. Andre, A. Fontanilles, and C. Dani, A role for preadipocytes as macrophage-like cells, FASEB J, vol.13, pp.305-312, 1999.
URL : https://hal.archives-ouvertes.fr/hal-00408791

G. Charriere, B. Cousin, E. Arnaud, M. Andre, and F. Bacou, Preadipocyte Conversion to Macrophage. EVIDENCE OF PLASTICITY, Journal of Biological Chemistry, vol.278, issue.11, pp.9850-9855, 2003.
DOI : 10.1074/jbc.M210811200

URL : https://hal.archives-ouvertes.fr/hal-00409046

H. Green and M. Meuth, An established pre-adipose cell line and its differentiation in culture, Cell, vol.3, issue.2, pp.127-133, 1974.
DOI : 10.1016/0092-8674(74)90116-0

L. Tailleux, N. Maeda, J. Nigou, B. Gicquel, and O. Neyrolles, How is the phagocyte lectin keyboard played? Master class lesson by Mycobacterium tuberculosis, Trends in Microbiology, vol.11, issue.6, pp.259-263, 2003.
DOI : 10.1016/S0966-842X(03)00102-1

S. Zimmerli, S. Edwards, and J. Ernst, Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages., American Journal of Respiratory Cell and Molecular Biology, vol.15, issue.6, pp.760-770, 1996.
DOI : 10.1165/ajrcmb.15.6.8969271

H. Itabe, I. Kudo, and K. Inoue, Preferential hydrolysis of oxidized phospholipids by peritoneal fluid of rats treated with casein, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.963, issue.2, pp.192-200, 1988.
DOI : 10.1016/0005-2760(88)90280-9

E. Blanchette-mackie, N. Dwyer, T. Barber, R. Coxey, and T. Takeda, Perilipin is located on the surface layer of intracellular lipid droplets in adipocytes, J Lipid Res, vol.36, pp.1211-1226, 1995.

D. Russell, Mycobacterium tuberculosis: here today, and here tomorrow, Nature Reviews Molecular Cell Biology, vol.59, issue.8, pp.569-577, 2001.
DOI : 10.1038/35085034

P. Mehta, C. King, E. White, J. Murtagh, and F. Quinn, Comparison of in vitro models for the study of Mycobacterium tuberculosis invasion and intracellular replication, Infect Immun, vol.64, pp.2673-2679, 1996.

N. Rastogi, V. Labrousse, and J. De-sousa, Mycobacterial growth and ultrastructure in mouse L-929 fibroblasts and bone marrow-derived macrophages: Evidence that infected fibroblasts secrete mediators capable of modulating bacterial growth in macrophages, Current Microbiology, vol.58, issue.Suppl. 2, pp.203-213, 1992.
DOI : 10.1007/BF01570720

T. Byrd, G. Green, S. Fowlston, and C. Lyons, Differential growth characteristics and streptomycin susceptibility of virulent and avirulent Mycobacterium tuberculosis strains in a novel fibroblast-mycobacterium microcolony assay, Infect Immun, vol.66, pp.5132-5139, 1998.

Y. Hu, A. Coates, and D. Mitchison, Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis, 2006.

D. Tyrrell, S. Mclauchlan, and C. Goodwin, The growth of some mycobacteria on cultured human tissues, Br J Exp Pathol, vol.56, pp.99-102, 1975.

C. Godard, Attempts to cultivate Mycobacterium leprae in fat tissue, Acta Leprol, vol.8, pp.133-135, 1993.

A. Kuniyasu, S. Hayashi, and H. Nakayama, Adipocytes recognize and degrade oxidized low density lipoprotein through CD36, Biochemical and Biophysical Research Communications, vol.295, issue.2, pp.319-323, 2002.
DOI : 10.1016/S0006-291X(02)00666-6

A. Kuniyasu, N. Ohgami, S. Hayashi, A. Miyazaki, and S. Horiuchi, CD36-mediated endocytic uptake of advanced glycation end products (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes, FEBS Letters, vol.266, issue.1-3, pp.85-90, 2003.
DOI : 10.1016/S0014-5793(03)00096-6

N. Garton, H. Christensen, D. Minnikin, R. Adegbola, and M. Barer, Intracellular lipophilic inclusions of mycobacteria in vitro and in sputum, Microbiology, vol.148, issue.10, pp.2951-2958, 2002.
DOI : 10.1099/00221287-148-10-2951

H. Alvarez and A. Steinbuchel, Triacylglycerols in prokaryotic microorganisms, Appl Microbiol Biotechnol, vol.60, pp.367-376, 2002.

P. Hart, J. Armstrong, and E. Brodaty, Calixarenes with host-mediated potency in experimental tuberculosis: further evidence that macrophage lipids are involved in their mechanism of action, Infect Immun, vol.64, pp.1491-1493, 1996.

S. Cole, R. Brosch, J. Parkhill, T. Garnier, and C. Churcher, Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence, Nature, vol.25, issue.6685, pp.537-544, 1998.
DOI : 10.1038/31159

Z. Yun, H. Maecker, R. Johnson, and A. Giaccia, Inhibition of PPAR??2 Gene Expression by the HIF-1-Regulated Gene DEC1/Stra13, Developmental Cell, vol.2, issue.3, pp.331-341, 2002.
DOI : 10.1016/S1534-5807(02)00131-4

D. De-wit, G. Maartens, and L. Steyn, A comparative study of the polymerase chain reaction and conventional procedures for the diagnosis of tuberculous pleural effusion, Tubercle and Lung Disease, vol.73, issue.5, pp.262-267, 1992.
DOI : 10.1016/0962-8479(92)90130-C

P. Seiler, T. Ulrichs, S. Bandermann, L. Pradl, and S. Jorg, in Latent Infection, The Journal of Infectious Diseases, vol.188, issue.9, pp.1326-1331, 2003.
DOI : 10.1086/378563

T. Ulrichs, M. Lefmann, M. Reich, L. Morawietz, and A. Roth, organisms and their precise localization in human tissue, The Journal of Pathology, vol.2, issue.4, pp.633-640, 2005.
DOI : 10.1002/path.1728

N. Stute, K. Holtz, M. Bubenheim, C. Lange, and F. Blake, Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use, Experimental Hematology, vol.32, issue.12, pp.1212-1225, 2004.
DOI : 10.1016/j.exphem.2004.09.003